Peter van de Kerkhof
Peter van de Kerkhof
Verifisert e-postadresse på radboudumc.nl
Sitert av
Sitert av
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ...
Nature genetics 44 (12), 1341-1348, 2012
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
CEM Griffiths, BE Strober, P Van De Kerkhof, V Ho, R Fidelus-Gort, ...
New England Journal of Medicine 362 (2), 118-128, 2010
European S3-guidelines on the systemic treatment of psoriasis vulgaris
D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, ...
Journal of the European Academy of Dermatology and Venereology 23 (SUPPL. 2 …, 2009
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions
BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ...
Journal of Investigative Dermatology 130 (7), 1785-1796, 2010
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
CEM Griffiths, K Reich, M Lebwohl, P Van De Kerkhof, C Paul, A Menter, ...
The Lancet 386 (9993), 541-551, 2015
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
KA Papp, S Tyring, M Lahfa, J Prinz, CEM Griffiths, AM Nakanishi, R Zitnik, ...
British Journal of Dermatology 152 (6), 1304-1312, 2005
Psoriasis is associated with increased β-defensin genomic copy number
EJ Hollox, U Huffmeier, PLJM Zeeuwen, R Palla, J Lascorz, ...
Nature genetics 40 (1), 23-25, 2008
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
MG Lebwohl, H Bachelez, J Barker, G Girolomoni, A Kavanaugh, ...
Journal of the American Academy of Dermatology 70 (5), 871-881. e30, 2014
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris–Update 2015–Short version–EDF in cooperation with EADV and IPC
A Nast, P Gisondi, AD Ormerod, P Saiag, C Smith, PI Spuls, P Arenberger, ...
Journal of the European Academy of Dermatology and Venereology 29 (12), 2277 …, 2015
Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin
HJ Bovenschen, PC Van De Kerkhof, PE Van Erp, R Woestenenk, ...
Journal of Investigative Dermatology 131 (9), 1853-1860, 2011
Leg ulcers: a review of their impact on daily life
A Persoon, MM Heinen, CJM Van Der Vleuten, MJ De Rooij, ...
Journal of Clinical Nursing 13 (3), 341-354, 2004
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey
L Dubertret, U Mrowietz, A Ranki, PCM Van De Kerkhof, S Chimenti, ...
British Journal of Dermatology 155 (4), 729-736, 2006
European consensus statement on phenotypes of pustular psoriasis
AA Navarini, AD Burden, F Capon, U Mrowietz, L Puig, S Köks, K Kingo, ...
Journal of the European Academy of Dermatology and Venereology 31 (11), 1792 …, 2017
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
K Kragballe, BT Gjertsen, D De Hoop, PCM Van de Kerkhof, T Karlsmark, ...
The Lancet 337 (8735), 193-196, 1991
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
H Bachelez, PCM Van De Kerkhof, R Strohal, A Kubanov, F Valenzuela, ...
The Lancet 386 (9993), 552-561, 2015
Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients
E De Jong, B Seegers, MK Gulinck, JBM Boezeman, PCM Van de Kerkhof
Dermatology 193 (4), 300-303, 1996
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis
GJ de Jongh, PLJM Zeeuwen, M Kucharekova, R Pfundt, PG van der Valk, ...
Journal of investigative dermatology 125 (6), 1163-1173, 2005
Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
PCM van de Kerkhof, CEM Griffiths, K Reich, CL Leonardi, A Blauvelt, ...
Journal of the American Academy of Dermatology 75 (1), 83-98. e4, 2016
Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
M Flendrie, WHPM Vissers, MCW Creemers, EMGJ de Jong, ...
Arthritis research & therapy 7, 1-11, 2005
Microbiome dynamics of human epidermis following skin barrier disruption
PLJM Zeeuwen, J Boekhorst, EH van den Bogaard, HD de Koning, ...
Genome biology 13, 1-18, 2012
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20